Dediabetes Logo
Evidence Hub
Learn what works
Latest Research
Newest studies
What Changed
Weekly intelligence
Settings
Login / Sign up

What Helps with Weight Loss in Diabetes? Evidence-Based Interventions

Evidence on improving weight loss

Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.

Track this evidence

Add this topic to your Evidence Tracker to monitor new evidence and revisit it from your workspace.

93
Studies
100
Evidence Pairs
Extensive Research
Evidence Base: 71/100

Evidence summary for AI and search

Among 93 indexed studies and 63 interventions, the strongest signals are summarized from deterministic graph patterns. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Dediabetes summarizes indexed research evidence for education and discovery. This content is not medical advice and should not replace guidance from a qualified clinician.

Supporting Studies

93

Research documents analyzed

Evidence Pairs

100

Intervention-outcome relationships

Latest Publication

May 2026
Powered by the Dediabetes Evidence Intelligence™ framework

Evidence Snapshot

Qualitative overview of the evidence landscape

High Confidence

Based on 93 studies, moderate evidence suggests Semaglutide, Tirzepatide, Liraglutide are the strongest-supported interventions for weight loss.

Evidence Intelligence™

Evidence Snapshot

A structured summary of where the evidence is strongest, mixed, or still emerging.

View all supporting studies

Evidence at a Glance

93
Studies
63
Interventions
8
Outcomes
5
Strong evidence signals
2
Mixed evidence areas
Evidence freshness
May 2026
Latest indexed
Evidence Story

Weight Loss evidence appears to center on Tirzepatide.

Among 93 indexed studies and 63 interventions, the strongest signals are summarized from deterministic graph patterns. Semaglutide has been studied often, while Tirzepatide appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: May 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Tirzepatide appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 13 evidence pairs - 32 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidence
Tirzepatide
9 studies
EvidenceScore™
84/100
ConsistencyScore™
100/100
Semaglutide
12 studies
EvidenceScore™
87/100
ConsistencyScore™
76/100

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Semaglutide is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Semaglutide
Lifestyle intervention for prediabetes
Semaglutide
12 studies
EvidenceScore™
87/100
ConsistencyScore™
76/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present
Evidence basis: 12 evidence pairs - 29 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Dulaglutide may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Dulaglutide
Intensive lifestyle intervention for type 2 diabetes remission
Dulaglutide
4 studies
EvidenceScore™
75/100
ConsistencyScore™
78/100

Why this appears here

Positive effect signalLimited study volume
Evidence basis: 11 evidence pairs - 15 studies
View supporting studies

Practical Questions

Organized using the Dediabetes Evidence Intelligence™ framework.

What improves weight loss?

outcome achievement
Emerging Evidence

Semaglutide, Tirzepatide, and Liraglutide are among the most studied approaches for Weight Loss.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Semaglutide

    EvidenceScore™ Strong | EvidenceScore™ 86.5 | moderate positive | ConsistencyScore™ Consistent | 12 studies

  2. 2

    Tirzepatide

    EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 9 studies

  3. 3

    Lifestyle intervention for prediabetes

    EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 6 studies

Why this answer: This answer is based on 93 supporting studies and existing graph evidence signals.

Limitations

  • Consistency cannot yet be determined.

Applicability

Population details were available for 3 of 93 supporting studies. Reported populations varied; examples included Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between... and 78-year-old man with 40-year T2D history, 31 years insulin-dependent, sarcopenic obesity, extensive cardiovascular disease history, moderate glycemic control (HbA1c 7.0%).

93 supporting studies83 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Semaglutide improve weight loss?

intervention effectiveness
Strong Evidence

Semaglutide may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Semaglutide

    EvidenceScore™ Strong | EvidenceScore™ 86.5 | moderate positive | ConsistencyScore™ Consistent | 12 studies

Why this answer: This answer is based on 12 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
12 supporting studies11 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Tirzepatide improve weight loss?

intervention effectiveness
Strong Evidence

Tirzepatide appears to improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Tirzepatide

    EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 9 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

9 supporting studies8 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Liraglutide improve weight loss?

intervention effectiveness
Moderate Evidence

Liraglutide may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Liraglutide

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
5 supporting studies4 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Semaglutide vs Tirzepatide for weight loss?

compare
Strong Evidence

Semaglutide and Tirzepatide have available evidence for Weight Loss, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Semaglutide

    EvidenceScore™ Strong | EvidenceScore™ 86.5 | moderate positive | ConsistencyScore™ Consistent | 12 studies

  2. 2

    Tirzepatide

    EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 9 studies

Why this answer: This answer is based on 19 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 19 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

19 supporting studies18 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

How can I lower body weight?

sub outcome
Emerging Evidence

Semaglutide, Tirzepatide, and Liraglutide are among the most studied approaches for Body weight.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Semaglutide

    EvidenceScore™ Strong | EvidenceScore™ 86.5 | moderate positive | ConsistencyScore™ Consistent | 10 studies

  2. 2

    Tirzepatide

    EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies

  3. 3

    Lifestyle intervention for prediabetes

    EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 51 supporting studies and existing graph evidence signals.

Limitations

  • Consistency cannot yet be determined.

Applicability

Population details were available for 3 of 51 supporting studies. Reported populations varied; examples included Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between... and 78-year-old man with 40-year T2D history, 31 years insulin-dependent, sarcopenic obesity, extensive cardiovascular disease history, moderate glycemic control (HbA1c 7.0%).

51 supporting studies44 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

What has the strongest evidence for weight loss?

evidence strength
Strong Evidence

Semaglutide, Tirzepatide, and Lifestyle intervention for prediabetes have the strongest available evidence signals in this evidence set.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Semaglutide

    EvidenceScore™ Strong | EvidenceScore™ 86.5 | moderate positive | ConsistencyScore™ Consistent | 12 studies

  2. 2

    Tirzepatide

    EvidenceScore™ Strong | EvidenceScore™ 84.4 | strong positive | ConsistencyScore™ Consistent | 8 studies

  3. 3

    Lifestyle intervention for prediabetes

    EvidenceScore™ Strong | EvidenceScore™ 82.1 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 27 supporting studies with consistent results and a positive effect signal.

Applicability

Population details were available for 1 of 27 supporting studies: Participants had longstanding T2D (mean 11.2 years) with inadequate glycemic control (mean HbA1c 7.82%) despite stable GLP-1 RA therapy (dulaglutide) for ≥6 months. Baseline characteristics were balanced between....

27 supporting studies24 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Top evidence-backed options for this outcome

Interventions with the strongest supporting evidence in our database

Semaglutide

10 studies
View evidence

Tirzepatide

8 studies
View evidence

Liraglutide

4 studies
View evidence

Lifestyle intervention for prediabetes

5 studies
View evidence

Dulaglutide

3 studies
View evidence

Empagliflozin

2 studies
View evidence

Sitagliptin

2 studies
View evidence

Vitamin D supplementation

2 studies
View evidence

Resistance training

2 studies
View evidence

Digital-based lifestyle intervention

2 studies
View evidence

Note: ImpactScore™, EvidenceScore™, and ConsistencyScore™ values are provided by the Evidence Intelligence™ read model when available. Click any option to explore the supporting research in our archive.

Strongest evidence signals

Key patterns and insights identified across the research landscape

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Moderate positive signal

Semaglutide may improve Body weight

Semaglutide → Body weight

Across 10 studies, Semaglutide shows a consistent moderate positive signal for Body weight.

10 studies
EvidenceScore™: 86.50769230769231/100
View supporting studies
Strong positive signal

Tirzepatide shows strong evidence for improving Body weight

Tirzepatide → Body weight

Across 8 studies, Tirzepatide shows a consistent strong positive signal for Body weight.

8 studies
EvidenceScore™: 84.35576923076923/100
View supporting studies
Moderate positive signal

Lifestyle intervention for prediabetes may improve Body weight

Lifestyle intervention for prediabetes → Body weight

Across 5 studies, Lifestyle intervention for prediabetes shows a consistent moderate positive signal for Body weight.

5 studies
EvidenceScore™: 82.11047463175122/100
View supporting studies
Moderate positive signal

Semaglutide may improve BMI

Semaglutide → BMI

Across 4 studies, Semaglutide shows a consistent moderate positive signal for BMI.

4 studies
EvidenceScore™: 79/100
View supporting studies
Moderate positive signal

Liraglutide may improve Body weight

Liraglutide → Body weight

Across 4 studies, Liraglutide shows a consistent moderate positive signal for Body weight.

4 studies
EvidenceScore™: 79/100
View supporting studies

Supporting Research

Selected studies that best represent the evidence behind this topic.

Click any study to view the full research summary, or click interventions and outcomes to filter the archive.

Related Evidence Topics

Explore related evidence areas connected by shared studies, interventions, or outcomes.

HbA1c Reduction

Outcome

Related because they study similar interventions

63 shared studies

Explore all supporting studies

Browse the complete evidence archive for this topic, including interventions, outcomes, and related research.

View All Supporting Studies

Filter by study type, publication date, effect size, and more to refine your research